Who
Daniel Raskas
Director
Company insider
Files Form 4 as: Director, Envista Holdings; SVP - Corporate Development, Danaher.
In numbers
- Trades disclosed
- 256
- Buys
- 0
- Sells
- 22
- Bought
- $0
- Sold
- $71.5M
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 1 Jan 2006
- Last trade
- 19 May 2026
- Last filed
- 21 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 19 May 2026filed 21 May 2026 | NVST Envista HoldingsMedical Devices | SEC FORM 4 Code A | —9,330 at $0.00 | filing |
| 19 May 2026filed 21 May 2026 | NVST Envista HoldingsMedical Devices | SEC FORM 4 Code A | —9,330 at $0.00 | filing |
| 10 Jun 2025filed 12 Jun 2025 | NVST Envista HoldingsMedical Devices | SEC FORM 4 Code A | —10,450 at $0.00 | filing |
| 3 Feb 2025filed 4 Feb 2025 | DHR DanaherLife-science tools | SEC FORM 4 Code F | $1.0M4,701 at $214.26 | filing |
| 1 Feb 2025filed 4 Feb 2025 | DHR Danaheroption or derivative · Life-science tools | SEC FORM 4 Code A | $160K720.5 at $222.74 | filing |
| 26 Nov 2024filed 27 Nov 2024 | DHR Danaheroption or derivative · Life-science tools | SEC FORM 4 Code M | —26,318 at $0.00 | filing |
| 26 Nov 2024filed 27 Nov 2024 | DHR DanaherLife-science tools | SEC FORM 4 Code M | $1.5M26,318 at $58.59 | filing |
| 26 Nov 2024filed 27 Nov 2024 | DHR DanaherLife-science tools | SEC FORM 4 Sold | $6.2M26,318 at $236.59 | filing |
| 25 Nov 2024filed 27 Nov 2024 | DHR DanaherLife-science tools | SEC FORM 4 Sold | $2.0M8,370 at $238.00 | filing |
| 25 Jul 2024filed 26 Jul 2024 | DHR DanaherLife-science tools | SEC FORM 4 Sold | $3.9M14,507 at $270.51 | filing |
| 21 May 2024filed 23 May 2024 | NVST Envista HoldingsMedical Devices | SEC FORM 4 Code A | —10,085 at $0.00 | filing |
| 1 Mar 2024filed 5 Mar 2024 | DHR Danaheroption or derivative · Life-science tools | SEC FORM 4 Code A | —10,469 at $0.00 | filing |
| 26 Feb 2024filed 27 Feb 2024 | DHR Danaheroption or derivative · Life-science tools | SEC FORM 4 Code M | —23,757 at $0.00 | filing |
| 26 Feb 2024filed 27 Feb 2024 | DHR DanaherLife-science tools | SEC FORM 4 Code G | —591 at $0.00 | filing |
| 26 Feb 2024filed 27 Feb 2024 | DHR DanaherLife-science tools | SEC FORM 4 Code M | $1.4M23,757 at $58.48 | filing |
| 26 Feb 2024filed 27 Feb 2024 | DHR DanaherLife-science tools | SEC FORM 4 Sold | $6.0M23,757 at $252.00 | filing |
| 21 Feb 2024filed 23 Feb 2024 | DHR DanaherLife-science tools | SEC FORM 4 Code A | —3,471 at $0.00 | filing |
| 1 Feb 2024filed 2 Feb 2024 | DHR Danaheroption or derivative · Life-science tools | SEC FORM 4 Code A | —700.9 at $0.00 | filing |
| 1 Feb 2024filed 2 Feb 2024 | DHR DanaherLife-science tools | SEC FORM 4 Code F | $1.5M5,984 at $245.13 | filing |
| 28 Jul 2023filed 1 Aug 2023 | DHR Danaheroption or derivative · Life-science tools | SEC FORM 4 Code M | —11,213 at $0.00 | filing |
News
Roper Technologies (ROP) vs. Danaher (DHR): Which Is the Better Long-Term Capital Allocator?DHR · insidermonkey.com · 18 Oct 2026Willow Creek Capital Management Inc. Purchases 2,796 Shares of Danaher Corporation $DHRDHR · dailypolitical.com · 17 Oct 2026Danaher's Stock Is Pricing in a Recovery. Can Its Earnings Deliver?DHR · insidermonkey.com · 16 Oct 2026
0 headlines in the last 90 days name Daniel Raskas; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.